Vectorious Medical Technologies said it has begun a first-in-human trial of its left atrial pressure monitoring device.
Tel Aviv-based Vectorius is developing the V-Lap implantable wireless heart monitor, which is designed to monitor pressure in the heart’s left atrium. The Vector-HF trial will enroll up to 30 patients at six sites across Germany, Israel, Italy and the U.K. The prospective, multicenter, single-arm, clinical trial was designed to assess the safety and performance of the V-LAP system in preparation for receiving the CE Mark.